Diabetes, Obesity and Metabolism

Cover image for Vol. 18 Issue 6

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: R. Donnelly and A. Garber

Impact Factor: 6.36

ISI Journal Citation Reports © Ranking: 2014: 14/128 (Endocrinology & Metabolism)

Online ISSN: 1463-1326


  1. 1 - 18

    1. Effects of Obeticholic Acid on Lipoprotein Metabolism in Healthy Volunteers

      Richard Pencek, Tonya Marmon, Jonathan D. Roth, Alexander Liberman, Roya Hooshmand-Rad and Mark Young

      Accepted manuscript online: 25 APR 2016 12:35AM EST | DOI: 10.1111/dom.12681


    1. Exenatide decreases Liver fat content and Epicardial Adipose Tissue in Patients with obesity and Type 2 Diabetes: A prospective randomised clinical trial using Magnetic Resonance Imaging and Spectroscopy

      A. Dutour, I. Abdesselam, P. Ancel, F. Kober, G. Mrad, P. Darmon, O. Ronsin, V. Pradel, N. Lesavre, J.C. Martin, A. Jacquier, Y. Lefur, M. Bernard and B. Gaborit

      Accepted manuscript online: 23 APR 2016 01:25AM EST | DOI: 10.1111/dom.12680


    1. Gastrointestinal safety across the albiglutide development programme

      Lawrence A. Leiter, Jason M. Mallory, Timothy H. Wilson and Rickey R. Reinhardt

      Accepted manuscript online: 21 APR 2016 06:35AM EST | DOI: 10.1111/dom.12679


    1. Role of E3 ubiquitin ligases in insulin resistance

      Xi-Ding Yang, Da-Xiong Xiang and Yong-Yu Yang

      Accepted manuscript online: 21 APR 2016 04:15AM EST | DOI: 10.1111/dom.12677

    2. Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications

      H. A. Dowlat, M. K. Kuhlmann, Hootan Khatami and F. J. Ampudia-Blasco

      Accepted manuscript online: 21 APR 2016 04:15AM EST | DOI: 10.1111/dom.12676


    1. Antiresorptive Therapy and Newly-Diagnosed Diabetes in Women: A Historical Cohort Study

      Shuman Yang, William D. Leslie, Suzanne N. Morin, Sumit R. Majumdar and Lisa M. Lix

      Accepted manuscript online: 21 APR 2016 04:15AM EST | DOI: 10.1111/dom.12678

    2. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZP-531, a First-in-class Analogue of Unacylated Ghrelin (UAG), in Healthy, Overweight/Obese, and Type 2 Diabetes Subjects

      Soraya Allas, Thomas Delale, Ngoc Ngo, Michel Julien, Pierre Sahakian, James Ritter, Thierry Abribat and Aart J van der Lely

      Accepted manuscript online: 10 APR 2016 09:20PM EST | DOI: 10.1111/dom.12675


    1. Change in HbA1c after Initiating Second-Line Therapy in Type 2 Diabetes: A Primary Care Database Study

      W. Rathmann, B. Bongaerts and K. Kostev

      Accepted manuscript online: 7 APR 2016 09:30AM EST | DOI: 10.1111/dom.12673


    1. Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomised, active comparator clinical trial

      Li Zang, Yu Liu, Jianlin Geng, Yong Luo, Fang Bian, Xiaofeng Lv, Jialin Yang, Jun Liu, Yongde Peng, Yukun Li, Yue Sun, Heidrun Bosch-Traberg and Yiming Mu

      Accepted manuscript online: 7 APR 2016 07:55AM EST | DOI: 10.1111/dom.12674


    1. Differential effects of once weekly GLP-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardised test meal in patients with type 2 diabetes

      Andrea Mari, Stefano Del Prato, Bernhard Ludvik, Zvonko Milicevic, Amparo de la Peña, Linda Shurzinske, Chrisanthi A. Karanikas and Valeria Pechtner

      Accepted manuscript online: 5 APR 2016 05:58AM EST | DOI: 10.1111/dom.12671


    1. Effects of multiple ascending doses of the glucagon receptor antagonist, PF-06291874, in patients with type 2 diabetes mellitus

      D. J. Kazierad, A. Bergman, B. Tan, D. M. Erion, V. Somayaji, D.S. Lee and T. Rolph

      Accepted manuscript online: 5 APR 2016 05:57AM EST | DOI: 10.1111/dom.12672

    2. Efficacy and safety of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Systematic review and network meta–analysis

      Francesco Zaccardi, David R Webb, Zin Z Htike, Dalia Youssef, Kamlesh Khunti and Melanie J Davies

      Accepted manuscript online: 5 APR 2016 05:57AM EST | DOI: 10.1111/dom.12670


    1. You have full text access to this OnlineOpen article
      Glucagon Orchestrates Stress-induced Hyperglycemia

      Joyce B. Harp, George D. Yancopoulos and Jesper Gromada

      Accepted manuscript online: 29 MAR 2016 02:05AM EST | DOI: 10.1111/dom.12668


    1. Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes

      Bruce H.R. Wolffenbuttel, Luc Van Gaal, Santiago Duran Garcia and Jenny Han

      Accepted manuscript online: 29 MAR 2016 02:05AM EST | DOI: 10.1111/dom.12669


    1. Efficacy and Safety of Combination Therapy with Vildagliptin and Metformin versus Metformin Up-Titration in Chinese Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy (VISION): A Randomized, Open-Label, Prospective Study

      Li-Nong Ji, Chang-Yu Pan, Ju-Ming Lu, Hong Li, Dalong Zhu, Qiang Li, Qi-Fu Li, Yong-De Peng, Hao-Ming Tian, Chen Yao, Zhi-Gang Zhao, Le Wang, Bin-Hui Wang and for the VISION Study Group

      Accepted manuscript online: 28 MAR 2016 04:00AM EST | DOI: 10.1111/dom.12667

    2. Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease

      L. A. Leiter, W. T. Cefalu, T. W. A. de Bruin, J. Xu, S. Parikh, E. Johnsson and I. Gause-Nilsson

      Accepted manuscript online: 24 MAR 2016 02:20AM EST | DOI: 10.1111/dom.12666

  13. Original Articles

    1. Comparative Cardiovascular Safety of Glucagon-Like Peptide-1 Receptor Agonists versus Other Antidiabetic Drugs in Routine Care: a Cohort Study

      Elisabetta Patorno, Brendan M. Everett, Allison B. Goldfine, Robert J. Glynn, Jun Liu, Chandrasekar Gopalakrishnan and Seoyoung C. Kim

      Accepted manuscript online: 22 MAR 2016 04:45AM EST | DOI: 10.1111/dom.12665


    1. The effect of adding insulin degludec in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)

      Vanita R. Aroda, Timothy S. Bailey, Bertrand Cariou, Sudhesh Kumar, Lawrence A. Leiter, Philip Raskin, Jeppe Zacho, Thomas H. Andersen and Athena Philis-Tsimikas

      Accepted manuscript online: 18 MAR 2016 04:50AM EST | DOI: 10.1111/dom.12661


  1. 1 - 18